Literature DB >> 10994725

Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age: relevance to the pathogenesis of bone loss.

V Carnevale1, F Dicembrino, V Frusciante, I Chiodini, S Minisola, A Scillitani.   

Abstract

UNLABELLED: Bone turnover changes with age have been shown by both histomorphometric and scintimetric methods; fewer studies have been performed on the regional differences of bone remodeling in the aging skeleton. To noninvasively investigate this issue, we evaluated the age-related patterns of global and regional bone uptake of 99mTc-methylene diphosphonate (MDP) in a large sample of healthy women.
METHODS: In a group of 84 healthy women (33 pre- and 51 postmenopausal), the uptake of 99mTcMDP was semiquantitatively measured in 5 regions of interest. Total-body digital scans (TBDSs) were acquired at 5 min and at 4 h. Five regions of interest were drawn on the skeleton as a whole, on the lumbar spine, on the iliac wing, on the femoral neck, and on the femoral diaphysis of the 4-h TBDS. Regional skeletal uptake of the lumbar spine (LS-RSU), of the iliac wing (IL-RSU), of the femoral neck (FN-RSU), and of the femoral diaphysis (FD-RSU) was calculated as percentage injected dose retained in these skeletal segments at 4 h.
RESULTS: As expected, in postmenopausal women the global skeletal uptake (GSU) values were higher than those in premenopausal women (40.7 +/- 5.9 percentage injected dose [%ID] versus 35.1 +/- 4.2 %ID; P < 0.0001). GSU correlated positively with age (r = 0.70; P < 0.001), but the addition of years since menopause to the regression model did not ameliorate the regression. On the other hand, LS-RSU (r = -0.55; P < 0.0001), IL-RSU (r = -0.45; P < 0.0001), and FN-RSU (r = -0.22; P < 0.005) decreased significantly, whereas FD-RSU increased significantly (r = 0.39; P < 0.001) with age; the same regressions were not influenced significantly by the addition of menopausal duration to the regression model. The strongest correlation among the different RSUs was that found between LS-RSU and IL-RSU (r = 0.63; P < 0.001). Moreover, the linear regression coefficients of the various RSUs with age were all significantly different from each other (P < 0.001).
CONCLUSION: Our data show that the GSU of 99mTc-MDP increases with age, whereas different skeletal segments display a variable degree of turnover activation at different ages. This could ultimately induce the different rates of bone loss of different skeletal segments at various ages and, consequently, their variable propensity to fracture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10994725

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study.

Authors:  Francesco Minisola; Cristiana Cipriani; Luciano Colangelo; Mirella Cilli; Alessandro Sciarra; Magnus Von Heland; Luciano Nieddu; Emanuela Anastasi; Roberto Pascone; Valeria Fassino; Daniele Diacinti; Flavia Longo; Salvatore Minisola; Jessica Pepe
Journal:  Endocrine       Date:  2017-06-28       Impact factor: 3.633

2.  Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause.

Authors:  Albert Shieh; Shinya Ishii; Gail A Greendale; Jane A Cauley; Joan C Lo; Arun S Karlamangla
Journal:  J Bone Miner Res       Date:  2016-10-21       Impact factor: 6.741

3.  Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Authors:  J Zhang; J Dai; Y Qi; D L Lin; P Smith; C Strayhorn; A Mizokami; Z Fu; J Westman; E T Keller
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Caspase-2 deficiency enhances aging-related traits in mice.

Authors:  Yingpei Zhang; Susan S Padalecki; Asish R Chaudhuri; Eric De Waal; Beth A Goins; Barry Grubbs; Yuji Ikeno; Arlan Richardson; Gregory R Mundy; Brian Herman
Journal:  Mech Ageing Dev       Date:  2006-12-22       Impact factor: 5.432

5.  The utility of bone scintigraphy in the assessment of mandibular metabolism during long-term bisphosphonate administration.

Authors:  Yumiko Ohbayashi; Fumi Nakai; Akinori Iwasaki; Takaaki Ogawa; Yuka Yamamoto; Yoshihiro Nishiyama; Minoru Miyake
Journal:  Odontology       Date:  2016-10-21       Impact factor: 2.634

Review 6.  Questioning the association between bisphosphonates and atypical femoral fractures.

Authors:  Michael Pazianas; Se-min Kim; Tony Yuen; Li Sun; Sol Epstein; Mone Zaidi
Journal:  Ann N Y Acad Sci       Date:  2014-10-07       Impact factor: 5.691

Review 7.  Bone as an effect compartment : models for uptake and release of drugs.

Authors:  David Stepensky; Lilach Kleinberg; Amnon Hoffman
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

Authors:  Albert Shieh; Weijuan Han; Shinya Ishii; Gail A Greendale; Carolyn J Crandall; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2016-06-23       Impact factor: 5.958

9.  Evaluation of cortical bone perfusion using dynamic contrast enhanced ultrashort echo time imaging: a feasibility study.

Authors:  Lidi Wan; Mei Wu; Vipul Sheth; Hongda Shao; Hyungseok Jang; Graeme Bydder; Jiang Du
Journal:  Quant Imaging Med Surg       Date:  2019-08

10.  Bone metabolism assessment, bone metabolism index designation and the determination of its normal values range in young healthy women.

Authors:  Wiesław Tryniszewski; Mariusz Gadzicki; Magdalena Górska-Chrząstek; Jacek Rysz; Zbigniew Maziarz
Journal:  Med Sci Monit       Date:  2011-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.